Mariko Tani1, Katalin V Horvath1, Benoit Lamarche2, Patrick Couture2, John R Burnett3, Ernst J Schaefer1, Bela F Asztalos4. 1. Cardiovascular Nutrition Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA. 2. Institute on Nutraceuticals and Functional Foods, Laval University, Québec, Canada. 3. Department of Clinical Biochemistry, Path West Laboratory Medicine, Royal Perth and Fiona Stanley Hospital Network and School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. 4. Cardiovascular Nutrition Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA. Electronic address: bela.asztalos@tufts.edu.
Abstract
BACKGROUND AND AIMS: Our aim was to gain insight into the role that lipoprotein lipase (LPL) and hepatic lipase (HL) plays in HDL metabolism and to better understand LPL- and HL-deficiency states. METHODS: We examined the apolipoprotein (apo) A-I-, A-II-, A-IV-, C-I-, C-III-, and E-containing HDL subpopulation profiles, assessed by native 2-dimensional gel-electrophoresis and immunoblotting, in 6 homozygous and 11 heterozygous LPL-deficient, 6 homozygous and 4 heterozygous HL-deficient, and 50 control subjects. RESULTS: LPL-deficient homozygotes had marked hypertriglyceridemia and significant decreases in LDL-C, HDL-C, and apoA-I. Their apoA-I-containing HDL subpopulation profile was shifted toward small HDL particles compared to controls. HL-deficient homozygotes had moderate hypertriglyceridemia, modest increases in LDL-C and HDL-C level, but normal apoA-I concentration. HL-deficient homozygotes had a unique distribution of apoA-I-containing HDL particles. The normally apoA-I:A-II, intermediate-size (α-2 and α-3) particles were significantly decreased, while the normally apoA-I only (very large α-1, small α-4, and very small preβ-1) particles were significantly elevated. In contrast to control subjects, the very large α-1 particles of HL-deficient homozygotes were enriched in apoA-II. Homozygous LPL- and HL-deficient subjects also had abnormal distributions of apo C-I, C-III, and E in HDL particles. Values for all measured parameters in LPL- and HL-deficient heterozygotes were closer to values measured in controls than in homozygotes. CONCLUSIONS: Our data are consistent with the concept that LPL is important for the maturation of small discoidal HDL particles into large spherical HDL particles, while HL is important for HDL remodeling of very large HDL particles into intermediate-size HDL particles.
BACKGROUND AND AIMS: Our aim was to gain insight into the role that lipoprotein lipase (LPL) and hepatic lipase (HL) plays in HDL metabolism and to better understand LPL- and HL-deficiency states. METHODS: We examined the apolipoprotein (apo) A-I-, A-II-, A-IV-, C-I-, C-III-, and E-containing HDL subpopulation profiles, assessed by native 2-dimensional gel-electrophoresis and immunoblotting, in 6 homozygous and 11 heterozygous LPL-deficient, 6 homozygous and 4 heterozygous HL-deficient, and 50 control subjects. RESULTS:LPL-deficient homozygotes had marked hypertriglyceridemia and significant decreases in LDL-C, HDL-C, and apoA-I. Their apoA-I-containing HDL subpopulation profile was shifted toward small HDL particles compared to controls. HL-deficient homozygotes had moderate hypertriglyceridemia, modest increases in LDL-C and HDL-C level, but normal apoA-I concentration. HL-deficient homozygotes had a unique distribution of apoA-I-containing HDL particles. The normally apoA-I:A-II, intermediate-size (α-2 and α-3) particles were significantly decreased, while the normally apoA-I only (very large α-1, small α-4, and very small preβ-1) particles were significantly elevated. In contrast to control subjects, the very large α-1 particles of HL-deficient homozygotes were enriched in apoA-II. Homozygous LPL- and HL-deficient subjects also had abnormal distributions of apo C-I, C-III, and E in HDL particles. Values for all measured parameters in LPL- and HL-deficient heterozygotes were closer to values measured in controls than in homozygotes. CONCLUSIONS: Our data are consistent with the concept that LPL is important for the maturation of small discoidal HDL particles into large spherical HDL particles, while HL is important for HDL remodeling of very large HDL particles into intermediate-size HDL particles.
Authors: Jonas Peterson; Amir F Ayyobi; Yuanhong Ma; Howard Henderson; Manuel Reina; Samir S Deeb; Silvia Santamarina-Fojo; Michael R Hayden; John D Brunzell Journal: J Lipid Res Date: 2002-03 Impact factor: 5.922
Authors: C M Ballantyne; J A Herd; L L Ferlic; J K Dunn; J A Farmer; P H Jones; J R Schein; A M Gotto Journal: Circulation Date: 1999-02-16 Impact factor: 29.690
Authors: Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer Journal: J Lipid Res Date: 2009-01-14 Impact factor: 5.922
Authors: Roshni R Singaraja; Suthesh Sivapalaratnam; Kees Hovingh; Marie-Pierre Dubé; José Castro-Perez; Heidi L Collins; Steven J Adelman; Meliana Riwanto; Jasmin Manz; Brian Hubbard; Ian Tietjen; Kenny Wong; Lyndon J Mitnaul; Margaret van Heek; Linus Lin; Thomas A Roddy; Jason McEwen; Geesje Dallinge-Thie; Leonie van Vark-van der Zee; Germaine Verwoert; Michael Winther; Cornelia van Duijn; Albert Hofman; Mieke D Trip; A David Marais; Bela Asztalos; Ulf Landmesser; Eric Sijbrands; John J Kastelein; Michael R Hayden Journal: Circ Cardiovasc Genet Date: 2012-12-14
Authors: Bela F Asztalos; Katalin V Horvath; Kouji Kajinami; Chorthip Nartsupha; Caitlin E Cox; Marcelo Batista; Ernst J Schaefer; Akihiro Inazu; Hiroshi Mabuchi Journal: J Lipid Res Date: 2003-12-01 Impact factor: 5.922
Authors: Isabelle L Ruel; Patrick Couture; Claude Gagne; Yves Deshaies; Jacques Simard; Robert A Hegele; Benoît Lamarche Journal: J Lipid Res Date: 2003-06-01 Impact factor: 5.922
Authors: Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks Journal: Arterioscler Thromb Vasc Biol Date: 2015-11-05 Impact factor: 8.311
Authors: Jonathan M Wilson; Amir Nikooienejad; Deborah A Robins; William C Roell; Jeffrey S Riesmeyer; Axel Haupt; Kevin L Duffin; Marja-Riitta Taskinen; Giacomo Ruotolo Journal: Diabetes Obes Metab Date: 2020-09-15 Impact factor: 6.577
Authors: Zsuzsanna Kuklenyik; Jeffery I Jones; Michael S Gardner; David M Schieltz; Bryan A Parks; Christopher A Toth; Jon C Rees; Michael L Andrews; Kayla Carter; Antony K Lehtikoski; Lisa G McWilliams; Yulanda M Williamson; Kevin P Bierbaum; James L Pirkle; John R Barr Journal: PLoS One Date: 2018-04-10 Impact factor: 3.240